| scholarly article | Q13442814 |
| P50 | author | William L Redmond | Q53850330 |
| P2093 | author name string | Annah S Rolig | |
| Mohammad Farhad | |||
| P2860 | cites work | Human galectin-3 is a novel chemoattractant for monocytes and macrophages | Q22254736 |
| Galectin-3 negatively regulates TCR-mediated CD4+ T-cell activation at the immunological synapse | Q24309257 | ||
| Expression of galectin-3 modulates T-cell growth and apoptosis | Q24309392 | ||
| Galectin-3 Determines Tumor Cell Adaptive Strategies in Stressed Tumor Microenvironments | Q26744513 | ||
| Proteomics. Tissue-based map of the human proteome | Q29617248 | ||
| IDO and galectin-3 hamper the ex vivo generation of clinical grade tumor-specific T cells for adoptive cell therapy in metastatic melanoma | Q33849567 | ||
| Galectin-3: an open-ended story | Q34494555 | ||
| Galectin-3 Shapes Antitumor Immune Responses by Suppressing CD8+ T Cells via LAG-3 and Inhibiting Expansion of Plasmacytoid Dendritic Cells | Q35329234 | ||
| Galectin-3 augments tumor initiating property and tumorigenicity of lung cancer through interaction with β-catenin | Q35741579 | ||
| Expression and function of galectin-3, a beta-galactoside-binding lectin, in human monocytes and macrophages. | Q35798551 | ||
| Cleavage of galectin-3 by matrix metalloproteases induces angiogenesis in breast cancer | Q35908448 | ||
| Analysis of the intracellular role of galectins in cell growth and apoptosis | Q36041236 | ||
| Galectin-3 as a Potential Target to Prevent Cancer Metastasis. | Q36326176 | ||
| New vistas on macrophage differentiation and activation | Q36689930 | ||
| Galectin-3 Cleavage Alters Bone Remodeling: Different Outcomes in Breast and Prostate Cancer Skeletal Metastasis | Q36891455 | ||
| Regulation of prostate cancer progression by galectin-3 | Q37164578 | ||
| Endogenous galectins and the control of the host inflammatory response | Q37373062 | ||
| Galectin-3 regulates T-cell functions | Q37548637 | ||
| Manipulating Cell Surface Glycoproteins by Targeting N-Glycan–Galectin Interactions | Q37785135 | ||
| Regulatory circuits mediated by lectin-glycan interactions in autoimmunity and cancer | Q37996614 | ||
| Glycans and galectins in prostate cancer biology, angiogenesis and metastasis | Q38221080 | ||
| Galectins in cancer: carcinogenesis, diagnosis and therapy | Q38269048 | ||
| Targeted disruption of the galectin-3 gene results in decreased susceptibility to NNK-induced lung tumorigenesis: an oligonucleotide microarray study | Q38294425 | ||
| Expression and function of galectin-3, a beta-galactoside-binding protein in activated T lymphocytes | Q38301765 | ||
| Galectin-3 expressed on different lung compartments promotes organ specific metastasis by facilitating arrest, extravasation and organ colonization via high affinity ligands on melanoma cells. | Q38306237 | ||
| Galectin-3 precipitates as a pentamer with synthetic multivalent carbohydrates and forms heterogeneous cross-linked complexes | Q38346878 | ||
| Increased expression of the LGALS3 (Galectin 3) gene in human non–small‐cell lung cancer | Q38355526 | ||
| Obstacles Posed by the Tumor Microenvironment to T cell Activity: A Case for Synergistic Therapies. | Q39178061 | ||
| Tumor microenvironment changes leading to resistance of immune checkpoint inhibitors in metastatic melanoma and strategies to overcome resistance | Q39424150 | ||
| A galectin-3 ligand corrects the impaired function of human CD4 and CD8 tumor-infiltrating lymphocytes and favors tumor rejection in mice | Q39666028 | ||
| Restoring the association of the T cell receptor with CD8 reverses anergy in human tumor-infiltrating lymphocytes | Q40002355 | ||
| Regulation of alternative macrophage activation by galectin-3. | Q40016366 | ||
| Differential expression of galectins in normal, benign and malignant prostate epithelial cells: silencing of galectin-3 expression in prostate cancer by its promoter methylation | Q40137078 | ||
| Galectin-3 and galectin-1 bind distinct cell surface glycoprotein receptors to induce T cell death | Q40333858 | ||
| Modulation of the biological functions of galectin-3 by matrix metalloproteinases | Q41064679 | ||
| Metabotropic glutamate receptor 5 may be involved in macrophage plasticity | Q41840818 | ||
| Differential expression of galectin-1 and galectin-3 during first trimester human embryogenesis | Q42443034 | ||
| Galectin-3, a Druggable Vulnerability for KRAS-Addicted Cancers | Q43465454 | ||
| Galectin-3 expression in prostate cancer and benign prostate tissues: correlation with biochemical recurrence | Q44523706 | ||
| Cancer-Associated Fibroblasts Are Activated in Incipient Neoplasia to Orchestrate Tumor-Promoting Inflammation in an NF-kappaB-Dependent Manner. | Q46127843 | ||
| Galectins: a family of animal beta-galactoside-binding lectins | Q48084852 | ||
| Proteome-wide Identification of Glycosylation-dependent Interactors of Galectin-1 and Galectin-3 on Mesenchymal Retinal Pigment Epithelial (RPE) Cells. | Q48334078 | ||
| Phylogenetic analysis of the vertebrate galectin family. | Q51037036 | ||
| Intravascular metastatic cancer cell homotypic aggregation at the sites of primary attachment to the endothelium. | Q52551217 | ||
| Mechanisms of action and rationale for the use of checkpoint inhibitors in cancer. | Q55060215 | ||
| Deletion of galectin-3 in the host attenuates metastasis of murine melanoma by modulating tumor adhesion and NK cell activity | Q61903522 | ||
| Galectin-3 is expressed in the notochord, developing bones, and skin of the postimplantation mouse embryo | Q72010083 | ||
| Normal development of mice carrying a null mutation in the gene encoding the L14 S-type lectin | Q72770432 | ||
| Involvement of decreased Galectin-3 expression in the pathogenesis and progression of prostate cancer | Q79847221 | ||
| Prognostic significance of endogenous adhesion/growth-regulatory lectins in lung cancer | Q81126619 | ||
| Galectin-1 and galectin-3 expression profiles in classically and alternatively activated human macrophages | Q82879773 | ||
| [The expression of galectin-3 and osteopontin in occult metastasis of non-small cell lung cancer] | Q84587668 | ||
| P275 | copyright license | Creative Commons Attribution-NonCommercial-NoDerivs 4.0 International | Q24082749 |
| P6216 | copyright status | copyrighted | Q50423863 |
| P433 | issue | 6 | |
| P921 | main subject | immunosuppression | Q1455316 |
| P304 | page(s) | e1434467 | |
| P577 | publication date | 2018-02-20 | |
| P1433 | published in | OncoImmunology | Q18026500 |
| P1476 | title | The role of Galectin-3 in modulating tumor growth and immunosuppression within the tumor microenvironment. | |
| P478 | volume | 7 |
| Q98290574 | Analysis of prognostic genes in the tumor microenvironment of lung adenocarcinoma |
| Q92013955 | Binding of Gold(III) Porphyrin by the Pro-metastatic Regulatory Protein Human Galectin-3 |
| Q57494712 | Clinical physiology and sleep: highlights from the European Respiratory Society Congress 2018 presented by early career members |
| Q90073141 | Galectin-3 as a Next-Generation Biomarker for Detecting Early Stage of Various Diseases |
| Q98499796 | Galectin-3 favours tumour metastasis via the activation of β-catenin signalling in hepatocellular carcinoma |
| Q63979922 | Galectins in prostate and bladder cancer: tumorigenic roles and clinical opportunities |
| Q64059939 | Galectins in the Pathogenesis of Cerebrovascular Accidents: An Overview |
| Q64274792 | Idiopathic Pulmonary Fibrosis and Lung Cancer: Mechanisms and Molecular Targets |
| Q92143839 | LGALS3 is connected to CD74 in a previously unknown protein network that is associated with poor survival in patients with AML |
| Q90690087 | Multifaceted effects of soluble human CD6 in experimental cancer models |
| Q92591588 | Prognostic Impact of Lymphoid Enhancer Factor 1 Expression and Serum Galectin.3 in Egyptian AML Patients |
| Q92037295 | Prognostic biomarkers for immunotherapy with ipilimumab in metastatic melanoma |
| Q99565582 | Quinoline-Pyrazole Scaffold as a Novel Ligand of Galectin-3 and Suppressor of TREM2 Signaling |
| Q64248384 | The Natural Cytotoxicity Receptors in Health and Disease |
| Q92130499 | The Number of Liver Galectin-3 Positive Cells Is Dually Correlated with NAFLD Severity in Children |
| Q99552019 | Trial Watch: experimental TLR7/TLR8 agonists for oncological indications |
| Q89736315 | Tumor Microenvironment-Associated Extracellular Matrix Components Regulate NK Cell Function |
| Q99711529 | Utilization of Galectins by Pathogens for Infection |
| Q92362848 | Vaccinations for Colorectal Cancer: Progress, Strategies, and Novel Adjuvants |
Search more.